BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23849342)

  • 1. Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1).
    Zhang X; Xing H; Feng X; Zhang H; Wang Y; Yan H
    Virol J; 2013 Jul; 10():232. PubMed ID: 23849342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay.
    Chen C; Jiang X; Liu X; Guo L; Wang W; Gu S; Wen C; Yi X; Tang L; Li Y
    J Leukoc Biol; 2021 Feb; 109(2):455-465. PubMed ID: 32620046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria.
    Iroezindu MO; Daniyam CA; Agbaji OO; Isa ES; Okeke EN; Imade GE
    J Infect Dev Ctries; 2013 Dec; 7(12):951-9. PubMed ID: 24334942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil.
    Mendes-Correa MC; Pinho JR; Gomes-Gouvea MS; da Silva AC; Guastini CF; Martins LG; Leite AG; Silva MH; Gianini RJ; Uip DE
    BMC Infect Dis; 2011 Sep; 11():247. PubMed ID: 21933423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.
    Jiang B; Su R; Ren D; Zheng X; Cao Y; Mi Y; Wang F; Ma P
    Virus Res; 2020 Dec; 290():198117. PubMed ID: 32800804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of antiviral therapy on virus-specific T-cell reactivity in patients with chronic hepatitis B].
    Feng X; Yan HP; Liao HY; Liu YM; Huang YL; Zhang GY; Lin F; Zhang X; Zhao Y; Zhang HP; Wang S; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):739-42. PubMed ID: 22781352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
    J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Tajik Z; Bokharaei-Salim F; Ghorbani S; Keyvani H; Esghaei M; Monavari SH; Ataei-Pirkooh A; Garshasbi S; Donyavi T; Fakhim A
    Arch Virol; 2018 Jun; 163(6):1559-1566. PubMed ID: 29476259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
    Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
    Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
    Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
    AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
    Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
    J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
    Miailhes P; Maynard-Muet M; Lebossé F; Carrat F; Bouix C; Lascoux-Combe C; Sogni P; Rey D; Barthe Y; Pol S; Cacoub P; Zoulim F; Piroth L
    J Hepatol; 2014 Oct; 61(4):761-9. PubMed ID: 24882048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
    Duan SP; Zhu LH; Hou LJ; Wang HW; Zhu XW; Hao J
    Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):421-426. PubMed ID: 34107578
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.
    Chang JJ; Sirivichayakul S; Avihingsanon A; Thompson AJ; Revill P; Iser D; Slavin J; Buranapraditkun S; Marks P; Matthews G; Cooper DA; Kent SJ; Cameron PU; Sasadeusz J; Desmond P; Locarnini S; Dore GJ; Ruxrungtham K; Lewin SR
    J Virol; 2009 Aug; 83(15):7649-58. PubMed ID: 19458009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of CD4+ T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children.
    Rouet F; Chaix ML; Kpozehouen A; Inwoley A; Anaky MF; Fassinou P; Rouzioux C; Blanche S; Msellati P
    J Trop Pediatr; 2009 Dec; 55(6):409-12. PubMed ID: 19447821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss.
    Zheng Q; Zhu YY; Chen J; Liu YR; You J; Dong J; Zeng DW; Gao LY; Chen LH; Jiang JJ
    J Viral Hepat; 2014 Dec; 21(12):909-16. PubMed ID: 24888640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.